In this large scale study, we evaluated whether there is an association between the prevalence of CD3+, CD4+, CD8+, CD20+ and CD45+ lymphocytes in tumors and survival prognosis in 249 non-GIST STS patients. The gene discussed is CD8A; the disease is gastrointestinal stromal tumor.